Structural and Kinetic Basis for Heightened Immunogenicity of T Cell Vaccines
Chen, J.-L., Stewart-Jones, G., Bossi, G., Lissin, N.M., Wooldridge, L., Choi, E.M.L., Held, G., Dunbar, P.R., Esnouf, R.M., Sami, M., Boultier, J.M., Rizkallah, P., Renner, C., Sewell, A., Van Der Merwe, P.A., Jackobsen, B.K., Griffiths, G., Jones, E.Y., Cerundolo, V.(2005) J Exp Med 201: 1243
- PubMed: 15837811 
- DOI: 10.1084/jem.20042323
- Primary Citation of Related Structures:  
2BNU, 2BNR, 2BNQ - PubMed Abstract: 
Analogue peptides with enhanced binding affinity to major histocompatibility class (MHC) I molecules are currently being used in cancer patients to elicit stronger T cell responses. However, it remains unclear as to how alterations of anchor residues may ...